Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Active Raynaud's Phenomenon
Stable disease and medication requirements over the previous two months
For Secondary Raynaud's Phenomenon subjects, a diagnosis of scleroderma using the American College of Rheumatology criteria or by the presence of at least 3/5 features of CREST syndrome
both sexes
You may not be if
Uncontrolled hypertension, diabetes mellitus, angina, or using oral nitrates
Smoking within 3 months or smoking cessation using nicotine products
Subjects currently taking sildenafil, tadalafil or vardenafil
Subjects with ulnar arterial occlusive disease as shown by a modified Allen test
Pregnant or breast feeding or considering pregnancy in next 4 months
Participation in trial for investigational drug within 30 days
